Print Page   |   Sign In   |   Create a Profile
News & Press: Industry News

Avi Pelossof Appointed President and CEO of Immucor

Friday, January 26, 2018   (0 Comments)
Posted by: Kristen Pappaterra
Share |
Avi Pelossof Appointed President and CEO of Immucor

Norcross, Georgia – January 16, 2018 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics and a portfolio company of global alternative asset firm TPG, today announced the appointment of Avi Pelossof as President and Chief Executive Officer, effective immediately. Pelossof succeeds CEO Jeffrey R. Binder (“Jeff”), who retains his role as Chairman of the Immucor Board of Directors. 

“Immucor has a capable, dynamic team that strives every day to meet the needs of our customers and their patients. It is exciting to welcome Avi as our new CEO, a seasoned healthcare executive with a proven track record,” said Binder. “I look forward to working with him in my role as Chairman of the Board to capitalize on the many opportunities ahead of us.”

Pelossof joins Immucor from Alere Inc., where he was most recently Global President for the Infectious Disease business, a $750 million unit focused on point-of-care infectious disease diagnostic tests. 

“Immucor is an established diagnostics leader with a strong track record of innovative products that meet the needs of transfusion and transplant customers worldwide,” said Pelossof. “I am honored to join the company at this time of great potential and look forward working with the talented team at Immucor to deliver results.” 

“Over the last number of years, Immucor has pursued significant growth, bringing new products to market and implementing a number of initiatives to further its global presence,” said Todd Sisitsky, Managing Partner of TPG Capital. “As we continue on this path, we are pleased to welcome Avi to the team. With more than 20 years of experience in the diagnostic space, he is the right leader to take Immucor forward.”

Sisitsky added, “As Chairman, Jeff will continue to lend his experience and expertise to Avi and the Immucor management team. 

Pelossof held a variety of positions while at Alere, including Vice President, Infectious Disease Strategic Business Unit and Vice President, Blood Borne Pathogens. Prior to Alere, Pelossof served as Senior Vice President, Sales, Marketing and Business Development for Chembio Diagnostics Systems, Inc., a developer, manufacturer and distributor of point-of-care diagnostic tests. He also held various positions focused on Latin America at Citibank, N.A./Citigroup and founded the consulting firm The IMS Group, Inc., focused on strategic market development for companies seeking to expand into Latin America. Pelossof has a BA in Economics from the University of Michigan and an MBA in Finance and International Business from New York University.

more Calendar

Swings Fore STEM Golf Outing 2018

Boehringer-Ingelheim Industry Tour

Membership Software Powered by YourMembership  ::  Legal